Author:
Cheng Yumeng,Mei Xiaofeng,Shao Wenbo,Zheng Jiaping,Yin Xiaohong,Zhang Qin,Li Jiansheng,Zhao Peng
Reference50 articles.
1. Idiopathic pulmonary fibrosis;Dj;N. Engl. J. Med.,2018
2. G. Raghu, B. Rochwerg, Y. Zhang, C.A.C. Garcia, A. Azuma, J. Behr, J.L. Brozek, H.R. Collard, W. Cunningham, S. Homma, T. Johkoh, F.J. Martinez, J. Myers, S.L. Protzko, L. Richeldi, D. Rind, M. Selman, A. Theodore, A.U. Wells, H. Hoogsteden, H.J. Schünemann, An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline, Am J Respir Crit Care Med 192 (2015) e3–e19. https://doi.org/10.1164/rccm.201506-1063ST.
3. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline;Raghu;Am. J. Respir. Crit. Care Med.,2022
4. Competitive cell death interactions in pulmonary infection: Host modulation versus pathogen manipulation;FitzGerald;Front. Immunol.,2020
5. Alveolar macrophages: Plasticity in a tissue-specific context;Hussell;Nat. Rev. Immunol.,2014